Welcome to LookChem.com Sign In|Join Free

CAS

  • or

7124-21-2

Post Buying Request

7124-21-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7124-21-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 7124-21-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,1,2 and 4 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 7124-21:
(6*7)+(5*1)+(4*2)+(3*4)+(2*2)+(1*1)=72
72 % 10 = 2
So 7124-21-2 is a valid CAS Registry Number.

7124-21-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 3,5-dimethylcyclohexane-1-carboxylic acid

1.2 Other means of identification

Product number -
Other names Opt.-inakt. 3.5-Dimethyl-cyclohexancarbonsaeure

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7124-21-2 SDS

7124-21-2Downstream Products

7124-21-2Relevant articles and documents

Enantio- and Regioselective Ir-Catalyzed Hydrogenation of Di- and Trisubstituted Cycloalkenes

Peters, Byron K.,Liu, Jianguo,Margarita, Cristiana,Rabten, Wangchuk,Kerdphon, Sutthichat,Orebom, Alexander,Morsch, Thomas,Andersson, Pher G.

supporting information, p. 11930 - 11935 (2016/10/07)

A number of cyclic olefins were prepared and evaluated for the asymmetric hydrogenation reaction using novel N,P-ligated iridium imidazole-based catalysts (Crabtree type). The diversity of these cyclic olefins spanned those having little functionality to

Cycloalkylamides and their therapeutic applications

-

, (2008/06/13)

The present invention relates to the use of compounds of formula (I) for the treatment of a variety of disorders including, but not limited to, epilepsy, bipolar disorder, psychiatric disorders, migraine, pain, neuroprotection, and movement disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 7124-21-2